Join        Login             Stock Quote

China Cord Blood (CO) Unit To Buy Cordlife's Interest In Shandong Province Qilu Stem Cells

 December 06, 2012 11:18 AM

(By Balaseshan) China Cord Blood Corp. (NYSE: CO), which provides umbilical cord blood stem cells storage, said its unit has agreed to buy Cordlife's interest in Shandong Province Qilu Stem Cells Engineering Co. Ltd.

Favorable Fort Ltd. has entered into a definitive agreement with Cordlife Services (S) Pte. Ltd., a subsidiary of the company's strategic affiliate Cordlife Ltd., a cord blood and tissue banking service provider listed on the Australian Securities Exchange.

Favorable Fort will acquire Cordlife's interest in the joint venture, which has a minority interest in Shandong Province Qilu Stem Cells Engineering Co. Ltd. (Qilu), the operator of Shandong Cord Blood Bank, for a cash consideration of $8.65 million.

[Related -Earning Scan: WILC, NPD, CO, HI, TAOM, CPRT, GEDU]

Upon completion of the transaction, China Cord Blood's effective equity interest in Qilu will increase from about 19.9% to 24.0%. The completion of this transaction will be subject to approval by Cordlife's shareholders.

The incremental increase in equity ownership of Qilu is consistent with the company's strategy to expand its China presence, and at the same time, streamlines the organizational structure of the Company.

The company engaged Roth Capital Partners to provide, and Roth Capital Partners has delivered, an opinion to the company's Board of Directors as to the fairness, from a financial point of view, of the transaction.

China Cord Blood is a Hong Kong-based company that provides umbilical cord blood storage services for parents to save cord blood stem cells on behalf of their children. It provides exclusive cord blood storage services in the Beijing Municipality, the Guangdong Province and the Zhejiang Province.

[Related -US Market Rises As Hurricane Irene Recedes; Financial Stocks Gain]

CO is trading up 0.38% at $2.67 on Thursday. The stock has been trading between $2.03 and $3.38 for the past 52 weeks.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageOn Being A Forced Seller in a Panic

No one wants to be a forced seller in a panic. So how does anyone get into that situation?  Two things: bad read on...

article imageECB's Quantitative Easing - QuitE Wrong

The eurozone has been doing fine without the ECB’s read on...

article imageCan You Invest Better Than Warren Buffett

Warren Buffett's investing strategy is simple: find companies worth investing in read on...

article imageMild Rebound In Housing Market

Expectations for a snapback in home construction from the winter lull were dampened somewhat in the latest read on...

Popular Articles

Daily Sector Scan
Partner Center

Related Articles:

Earning Scan: DCI, LDK, PSEC, CWST, CO
More Articles on: Medical , China

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.